Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 2601-2607

  Di, Bei Bing ^a   Li, Hong Wei ^a   Li, Wei Ping ^a   Shen, Xu Hua ^a   Sun, Zhi Jun ^a   Wu, Xing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Nuclear factor B; Peroxisome proliferator activated receptor ; Pioglitazone; Reactive oxygen species; Receptor for advanced glycation end products

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ADVANCED GLYCATION END PRODUCT RECEPTOR; DIPHENYLIODONIUM SALT; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PIOGLITAZONE; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; IMMUNOGLOBULIN RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CORONARY BLOOD VESSEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

RATTUS;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANILIDES; ANIMALS; CORONARY VESSELS; GENE EXPRESSION REGULATION; GLUCOSE; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PPAR GAMMA; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; THIAZOLIDINEDIONES;

EID: 84921386189     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3113     Document Type: Article

References (22)

1. Hofmann MA, Drury S, Fu C, et al: RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S10 0/calgranulin polypeptides. Cell 97: 889-901, 1999.
2. Bierhaus A and Nawroth PP: Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immuneresponses and diabetes mellitus and its complications. Diabetologia 52: 2251-2263, 2009.
3. Leclerc E, Fritz G, Vetter SW and Heizmann CW: Binding of S100 proteins to RAGE: An update. Biochim. Biophys. Acta 1793: 993-1007, 2009.
4. Gao X, Zhang HR, Schmidt AM and Zhang C: AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice. Am J Physiol Heart Circ Physiol 295: H491-H498, 2008.
5. Sakaguchi T, Yan SF, Yan SD, et al: Central role of rage dependent neointimal expansion in arterial restenosis. J Clin Invest 111: 959-972, 2003.
6. Cipollone F, Iezzi A, Fazia M, et al: The receptor rage as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: Role of glycemic control. Circulation 108: 1070-1077, 2003.
7. Wang K, Zhou Z, Zhang M, et al: Peroxisome proliferator activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther 317 37-43, 2006.
8. De Oliveira C, Colette C, Monnier L, Descomps B and Pares-Herbute N: Insulin alters nuclear factor-lambdab and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells. J Lab Clin Med 145: 1440-1450, 2005
9. Li H, Chai Q, Gutterman DD and Liu Y: Elevated glucose impairs cAMP mediated dilation by reducing Kv channel activity in rat small coronary smooth muscle. Am J Physiol Heart Circ Physiol 285: H1213-H1219, 2003.
10. Yoon SJ, Yoon YW, Lee BK, et al: Potential role of hmg coareductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy. Exp Mol Med 41: 802-811, 2009
11. Yoon YW, Kang TS, Lee BK, et al: Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med 40: 398-406, 2008.
12. San Martin A, Foncea R, Laurindo FR, et al: Nox1-based nadph oxidase-derived superoxide is required for vsmc activation by advanced glycation end-products. Free Radic Biol Med 42: 1671-1679, 2007
13. Sakata N, Meng J and Takebayashi S: Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb 7: 169-176, 2000.
14. Ren X, Shao H, Wei Q, Sun Z and Liu N: Advanced glycation end products enhance calcification in vascular smooth muscle cells. J Int Med Res 37 847-854, 2009
15. Tanikawa T, Okada Y, Tanikawa R and Tanaka Y: Advanced glycation end products induce calcification of vascular smooth muscle cells through rage/p38 mapk. J Vasc Res 46: 572-580, 2009
16. Wei Q, Ren X, Jiang Y, Jin H, Liu N and Li J: Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. BMC Cardiovasc Disord 13: 13, 2013.
17. Hayakawa E, Yoshimoto T, Sekizawa N, Sugiyama T and Hirata Y: Overexpression of receptor for advanced glycation end products induced monocyte chemoattractant protein-1 expression in rat vasculat smooth muscle cell line. J Atheroscler Thromb 19: 13-22, 2012.
18. Soro-Paavonen A, Watson AM, Li J, Paavonen K, et al: Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57 2461-2469, 2008.
19. Bu DX, Rai V, Shen X, et al: Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice. Circ. Res 106: 1040-1051, 2010.
20. Ueno H, Koyama H, Shoji T, et al: Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse. Atherosclerosis 211: 431-436, 2010.
21. Li J and Schmidt AM: Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272: 16498-16506, 1997
22. Yuan X1, Zhang Z, Gong K, Zhao P, Qin J and Liu N: Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats. Biol Pharm Bull. 34: 618-623, 2011.